--- title: "Extraneous ePrescription Notes: Best Addressed by the Sender" description: "Extraneous ePrescription Notes: Best Addressed by the Sender" --- [![logo](https://blog.pocp.com/hs-fs/hubfs/logo/logo.jpg?width=250&height=77&name=logo.jpg "logo")](https://www.pocp.com/) # Accelerating client's success # using Health IT and # business process solutions... [Learn More](https://www.pocp.com/the-pocp-story/) # Simplifying # regulatory ## compliance... [Learn More](https://www.pocp.com/regulatory-resource-center/) # Creating value in today's # healthcare ecosystem... [Learn More](https://www.pocp.com/our-client/) - Consulting - [Strategy & Market Intelligence](https://www.pocp.com/strategy-market-intelligence/) - [Education & Research](https://www.pocp.com/education-research/) - [Value-Based Care Interoperability Roadmap](https://info.pocp.com/en-us/value-based-care-interoperability-strategy-and-roadmap) - [Multi-stakeholder Collaboratives, Program Design and Management](https://www.pocp.com/multi-stakeholder-initiatives_program-design_management) - [EHR Training Programs](https://www.pocp.com/ehr-training-programs/) - [Life Sciences](https://www.pocp.com/life-sciences) - [Regulatory Resource Center](https://www.pocp.com/regulatory-resource-center) - About Us - [The POCP Story](https://www.pocp.com/the-pocp-story/) - [Our Clients](https://www.pocp.com/our-client/) - [Health & IT Vendors](https://www.pocp.com/our-client/health-it-vendors/) - [Payers & PBMS](https://www.pocp.com/our-client/payers-pbms/) - [Accountable Care](https://www.pocp.com/our-client/accountable-care/) - [Health Information Exchange](https://www.pocp.com/resource-library/health-information-exchange/) - [Our Team](https://www.pocp.com/our-team/) - [Government Contracting](https://info.pocp.com/gsa) - [Press](https://www.pocp.com/press/) - [Calendar](https://info.pocp.com/en-us/events) - [Careers at POCP](https://www.pocp.com/the-pocp-story/careers-at-pocp/) - Insights - [Articles and Industry Comments](https://www.pocp.com/articles/) - [Blog](https://blog.pocp.com/blog/) - [Newsletters HIT Perspectives](https://www.pocp.com/insight/newsletters-2/) - [Newsletters Biopharma](https://www.pocp.com/newsletters-biopharma/) - [POCP Industry Reports](https://www.pocp.com/industry-reports) - [POCP Industry Reports](https://www.pocp.com/industry-reports) - [ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy](https://www.pocp.com/downloads/ePAReport) - [Real-Time Pharmacy Benefit Check Report](https://www.pocp.com/pocp-industry-reports/real-time-pharmacy-benefit-check-report/) - [Fighting the Opioid Epidemic at the State- and Rx-Level Report](https://www.pocp.com/downloads/fighting-opioid-epidemic-at-rx-level-report) - [ePrescribing State Law On-Demand](https://www.pocp.com/downloads/eprescribing-state-law-on-demand/) - [State Law Review](https://www.pocp.com/statelawreview/) - [Navigator](https://www.pocp.com/navigator/) - [Podcasts](https://info.pocp.com/en-us/the-dish-on-health-it-podcast) - [Presentations and Webinars](https://www.pocp.com/presentations/) - [Resource Library](https://www.pocp.com/resource-library/) - [White Papers, Webinars and Case Studies](https://www.pocp.com/white-papers-webinars-and-case-studies-2/) - [Our video channel](https://www.pocp.com/our-video-channel) - [Contact](https://www.pocp.com/contact/) - Consulting - [Strategy & Market Intelligence](https://www.pocp.com/strategy-market-intelligence/) - [Education & Research](https://www.pocp.com/education-research/) - [Value-Based Care Interoperability Roadmap](https://info.pocp.com/en-us/value-based-care-interoperability-strategy-and-roadmap) - [Multi-stakeholder Collaboratives, Program Design and Management](https://www.pocp.com/multi-stakeholder-initiatives_program-design_management) - [EHR Training Programs](https://www.pocp.com/ehr-training-programs/) - [Life Sciences](https://www.pocp.com/life-sciences) - [Regulatory Resource Center](https://www.pocp.com/regulatory-resource-center) - About Us - [The POCP Story](https://www.pocp.com/the-pocp-story/) - [Our Clients](https://www.pocp.com/our-client/) - [Health & IT Vendors](https://www.pocp.com/our-client/health-it-vendors/) - [Payers & PBMS](https://www.pocp.com/our-client/payers-pbms/) - [Accountable Care](https://www.pocp.com/our-client/accountable-care/) - [Health Information Exchange](https://www.pocp.com/resource-library/health-information-exchange/) - [Our Team](https://www.pocp.com/our-team/) - [Government Contracting](https://info.pocp.com/gsa) - [Press](https://www.pocp.com/press/) - [Calendar](https://info.pocp.com/en-us/events) - [Careers at POCP](https://www.pocp.com/the-pocp-story/careers-at-pocp/) - Insights - [Articles and Industry Comments](https://www.pocp.com/articles/) - [Blog](https://blog.pocp.com/blog/) - [Newsletters HIT Perspectives](https://www.pocp.com/insight/newsletters-2/) - [Newsletters Biopharma](https://www.pocp.com/newsletters-biopharma/) - [POCP Industry Reports](https://www.pocp.com/industry-reports) - [POCP Industry Reports](https://www.pocp.com/industry-reports) - [ePrior Authorization’s Real Benefits: Reducing Frictional Costs and Speeding Time to Therapy](https://www.pocp.com/downloads/ePAReport) - [Real-Time Pharmacy Benefit Check Report](https://www.pocp.com/pocp-industry-reports/real-time-pharmacy-benefit-check-report/) - [Fighting the Opioid Epidemic at the State- and Rx-Level Report](https://www.pocp.com/downloads/fighting-opioid-epidemic-at-rx-level-report) - [ePrescribing State Law On-Demand](https://www.pocp.com/downloads/eprescribing-state-law-on-demand/) - [State Law Review](https://www.pocp.com/statelawreview/) - [Navigator](https://www.pocp.com/navigator/) - [Podcasts](https://info.pocp.com/en-us/the-dish-on-health-it-podcast) - [Presentations and Webinars](https://www.pocp.com/presentations/) - [Resource Library](https://www.pocp.com/resource-library/) - [White Papers, Webinars and Case Studies](https://www.pocp.com/white-papers-webinars-and-case-studies-2/) - [Our video channel](https://www.pocp.com/our-video-channel) - [Contact](https://www.pocp.com/contact/) # Insights: Brief Points of View # POCP Blog --- ## Extraneous ePrescription Notes: Best Addressed by the Sender - March 29, 2016 - By [Michael Burger](https://blog.pocp.com/blog/author/michael-burger) - [0 Comment](https://blog.pocp.com/blog/extraneous-eprescription-notes-best-addressed-by-the-sender#comments-listing) Share this story: By [Michael Burger](https://pocp.com/team/michael-burger/), Senior Consultant A study was published recently in the JAMA ([link here](http://archinte.jamanetwork.com/article.aspx?articleID=2498845)) titled, “Analysis of Prescribers’ Notes in Electronic Prescriptions in Ambulatory Practice.” The study found a high number of instances where extraneous data was included in the free form notes section of electronic prescriptions (ePrescriptions) by prescribers using electronic prescribing (ePrescribing) software. In the study, of more than 26,000 ePrescriptions which contained free form notes, 66% contained what the authors consider to be inappropriate. 19% of these free form notes included directions that conflicted with directions contained elsewhere in the ePrescription. I agree that the inappropriate use of the free text prescriber notes field in an ePrescription is an issue that must be addressed, especially from the patient safety perspective.   I also concur in part with the authors’ conclusion that accelerated implementation of existing and new ePrescribing electronic data interchange (EDI) standards would address a sizable number of these issues. The study also suggests the need for “better prerelease usability testing, rigorous post-marketing evaluation and surveillance of EHR or ePrescribing software applications.”  On this point, I believe that the authors have missed the mark. In my days as an EHR product manager, one of my usability-tester clients used this analogy to describe using the EHR. He said “Imagine composing an email using only words and phrases from pull down menus. That’s what it’s like to write a prescription using the EHR.”  Sometimes there is information that needs to be relayed to the pharmacist.  And while some (or maybe most) of that information could be tediously selected from pulldown lists, one piece at a time, sometimes a prescriber decides that it’s just quicker and easier to type it out as free form text.  So to say that EHRs are poorly designed and not user friendly is not a fair criticism. The process of ePrescribing by selecting individual components of data is not as "user friendly" as the process of writing a free form prescription on a piece of paper, regardless of the design of the software. It is fair to say that the current design of ePrescribing software doesn’t accommodate certain kinds of ePrescribing well. For oral solids like pills and capsules, ePrescribing works great.  For liquids, ointments, injectables and compound drugs, not as well. In this area, I agree with the authors’ conclusion that “consistent end user training and feedback” is needed. Existing software can be appropriately used to order these not-easy-to-ePrescribe product categories.  But appropriate ordering may require prescribers to rethink how they order.  Instead of ordering “one tube,” they’ll need to order an appropriate number of grams or milligrams. One ePrescribing challenge today is that there isn’t a feedback loop from pharmacist to prescriber. If the pharmacist receives an ePrescription containing conflicting or extraneous information, the prescriber isn’t typically notified by the pharmacist that there is an ePrescribing-related issue. The clarifying phone call is most frequently fielded by a nurse, not the prescriber. And the question is one of clarification of the prescriber’s intent – not an attempt to address the root cause of the issue. There also seems to be a misconception of EHR vendors’ role in this equation. Vendors aren’t (and shouldn’t be) placed in a position of enforcement. If users of the software are sending extraneous information in the prescription, the discussion should be between the pharmacist and the prescriber. \[tweetthis\]It isn’t the #EHR vendors’ role to surveil their customers’ use of their products. \[/tweetthis\] It isn’t a fair characterization of EHR vendors to assume that they don’t perform usability testing or post marketing evaluation of their products. Frankly, if they didn’t, they’d be out of business because no one would buy inferior software.  It isn’t the vendors’ role to surveil their customers’ use of their products. If I don’t like the contents of a letter that I receive, I don’t talk to the letter carrier.  Nor do I talk to the manufacturer of the vehicle that the letter carrier is driving. Instead I talk to the sender of the letter. In the same way, if the pharmacist is receiving incorrect or extraneous data from the prescriber, the pharmacist and the prescriber should work that out. I also observe that physicians are taught how to write prescriptions, on paper, in medical school.  I’m not aware of a study in which paper prescriptions have been evaluated to determine if there was “inappropriate information” included. I would wager that most of the same types of extraneous information being transmitted electronically is also included on paper prescriptions. So these “old habits” may be hard to break. I am an avid proponent of more accurate and safer ePrescribing. It defeats the efficiencies that are gained by ePrescribing if such a high number of ePrescriptions require follow up to clarify the prescriber’s intent. Rather than place the burden for process improvement primarily on the EHR vendors, I believe that a more balanced approach would be to involve the prescribers and the pharmacists.  A quick and to-the-point conversation is likely all it will take. - Post Categories - [EHR](https://blog.pocp.com/blog/tag/ehr) - [Uncategorized](https://blog.pocp.com/blog/tag/uncategorized) - [ePrescribing](https://blog.pocp.com/blog/tag/eprescribing) # POCP Blog --- Search - There are no suggestions because the search field is empty. ### RECENT POSTS ### CATEGORIES - [Interoperability (39)](https://blog.pocp.com/blog/tag/interoperability) - [Health IT Policy (38)](https://blog.pocp.com/blog/tag/health-it-policy) - [CMS (28)](https://blog.pocp.com/blog/tag/cms) - [EHR (24)](https://blog.pocp.com/blog/tag/ehr) - [FHIR (24)](https://blog.pocp.com/blog/tag/fhir) - [Health IT Trends (20)](https://blog.pocp.com/blog/tag/health-it-trends) - [ePrescribing (19)](https://blog.pocp.com/blog/tag/eprescribing) - [Prior Authorization (16)](https://blog.pocp.com/blog/tag/prior-authorization) - [Real-Time Benefit Check (15)](https://blog.pocp.com/blog/tag/real-time-benefit-check) - [Real-Time Pharmacy Benefit Check (15)](https://blog.pocp.com/blog/tag/real-time-pharmacy-benefit-check) - [Regulatory Trends (15)](https://blog.pocp.com/blog/tag/regulatory-trends) - [APIs (13)](https://blog.pocp.com/blog/tag/apis) - [Artificial Intelligence (12)](https://blog.pocp.com/blog/tag/artificial-intelligence) - [electronic prior authorization (12)](https://blog.pocp.com/blog/tag/electronic-prior-authorization) - [health IT (12)](https://blog.pocp.com/blog/tag/health-it) - [Life Sciences (10)](https://blog.pocp.com/blog/tag/life-sciences) - [NCPDP (10)](https://blog.pocp.com/blog/tag/ncpdp) - [Policy (10)](https://blog.pocp.com/blog/tag/policy) - [electronic health records (9)](https://blog.pocp.com/blog/tag/electronic-health-records) - [pharmacy interoperability (9)](https://blog.pocp.com/blog/tag/pharmacy-interoperability) - [ASTP (8)](https://blog.pocp.com/blog/tag/astp) - [CMS NPRM (8)](https://blog.pocp.com/blog/tag/cms-nprm) - [health information exchange (8)](https://blog.pocp.com/blog/tag/health-information-exchange) - [HL7 (7)](https://blog.pocp.com/blog/tag/hl7) - [Payer (7)](https://blog.pocp.com/blog/tag/payer) - [Specialty Pharmacy (7)](https://blog.pocp.com/blog/tag/specialty-pharmacy) - [Standards Development (7)](https://blog.pocp.com/blog/tag/standards-development) - [TEFCA (7)](https://blog.pocp.com/blog/tag/tefca) - [Value-Based Care (7)](https://blog.pocp.com/blog/tag/value-based-care) - [e-Prescribing (7)](https://blog.pocp.com/blog/tag/e-prescribing) - [electronic prescribing (7)](https://blog.pocp.com/blog/tag/electronic-prescribing) - [Da Vinci Project (6)](https://blog.pocp.com/blog/tag/da-vinci-project) - [HTI-2 (6)](https://blog.pocp.com/blog/tag/hti-2) - [ONC (6)](https://blog.pocp.com/blog/tag/onc) - [Strategy and Research (6)](https://blog.pocp.com/blog/tag/strategy-and-research) - [healthcare reform (6)](https://blog.pocp.com/blog/tag/healthcare-reform) - [21st Century Cures Act (5)](https://blog.pocp.com/blog/tag/21st-century-cures-act) - [Consent (5)](https://blog.pocp.com/blog/tag/consent) - [EPCS (5)](https://blog.pocp.com/blog/tag/epcs) - [Federal Healthcare Policy (5)](https://blog.pocp.com/blog/tag/federal-healthcare-policy) - [HHS (5)](https://blog.pocp.com/blog/tag/hhs) - [Information Blocking (5)](https://blog.pocp.com/blog/tag/information-blocking) - [NCPDP SCRIPT (5)](https://blog.pocp.com/blog/tag/ncpdp-script) - [Patient Data (5)](https://blog.pocp.com/blog/tag/patient-data) - [Payer Interoperability (5)](https://blog.pocp.com/blog/tag/payer-interoperability) - [Pharmacy (5)](https://blog.pocp.com/blog/tag/pharmacy) - [health equity (5)](https://blog.pocp.com/blog/tag/health-equity) - [pharmaceutical marketing (5)](https://blog.pocp.com/blog/tag/pharmaceutical-marketing) - [population health (5)](https://blog.pocp.com/blog/tag/population-health) - [Clinical Decision Support (4)](https://blog.pocp.com/blog/tag/cds) - [Digital Health Programs (4)](https://blog.pocp.com/blog/tag/digital-health-programs) - [Digital Therapeutics (4)](https://blog.pocp.com/blog/tag/digital-therapeutics) - [EHR Dashboard (4)](https://blog.pocp.com/blog/tag/ehr-dashboard) - [EHR Usability (4)](https://blog.pocp.com/blog/tag/ehr-usability) - [HIE (4)](https://blog.pocp.com/blog/tag/hie) - [Health Plans (4)](https://blog.pocp.com/blog/tag/health-plans) - [Health Technology Solutions (4)](https://blog.pocp.com/blog/tag/health-technology-solutions) - [Meaningful Use (4)](https://blog.pocp.com/blog/tag/meaningful-use) - [PDMP (4)](https://blog.pocp.com/blog/tag/pdmp) - [Pharmacy Benefit Management (4)](https://blog.pocp.com/blog/tag/pharmacy-benefit-management) - [Strategic roadmap (4)](https://blog.pocp.com/blog/tag/strategic-roadmap) - [burden reduction (4)](https://blog.pocp.com/blog/tag/burden-reduction) - [ePrior Authorization (4)](https://blog.pocp.com/blog/tag/eprior-authorization) - [healthcare regulations (4)](https://blog.pocp.com/blog/tag/healthcare-regulations) - [pharmacy advance practice (4)](https://blog.pocp.com/blog/tag/pharmacy-advance-practice) - [price transparency (4)](https://blog.pocp.com/blog/tag/price-transparency) - [COVID-19 (3)](https://blog.pocp.com/blog/tag/covid-19) - [Clinical Calculators (3)](https://blog.pocp.com/blog/tag/clinical-calculators) - [Data Governance (3)](https://blog.pocp.com/blog/tag/data-governance) - [Diabetes Care (3)](https://blog.pocp.com/blog/tag/diabetes-care) - [Digital Health (3)](https://blog.pocp.com/blog/tag/digital-health) - [Drug price transparency (3)](https://blog.pocp.com/blog/tag/drug-price-transparency) - [EHR Reports (3)](https://blog.pocp.com/blog/tag/ehr-reports) - [HIMSS (3)](https://blog.pocp.com/blog/tag/himss) - [Healthcare AI (3)](https://blog.pocp.com/blog/tag/healthcare-ai) - [Implementation (3)](https://blog.pocp.com/blog/tag/implementation) - [Innovation (3)](https://blog.pocp.com/blog/tag/innovation) - [Medication Therapy Management (3)](https://blog.pocp.com/blog/tag/mtm) - [National Patient Identifier (3)](https://blog.pocp.com/blog/tag/national-patient-identifier) - [Patient Safety (3)](https://blog.pocp.com/blog/tag/patient-safety) - [Pharmacy Benefit (3)](https://blog.pocp.com/blog/tag/pharmacy-benefit) - [Request for Information (3)](https://blog.pocp.com/blog/tag/request-for-information) - [Speed to Therapy (3)](https://blog.pocp.com/blog/tag/speed-to-therapy) - [state prescribing laws (3)](https://blog.pocp.com/blog/tag/state-prescribing-laws) - [Administrative Burden (2)](https://blog.pocp.com/blog/tag/administrative-burden) - [CDC (2)](https://blog.pocp.com/blog/tag/cdc) - [Centers for Disease Control (2)](https://blog.pocp.com/blog/tag/centers-for-disease-control) - [Controlled Substances (2)](https://blog.pocp.com/blog/tag/controlled-substances) - [Data Efficiency (2)](https://blog.pocp.com/blog/tag/data-efficiency) - [EHR Certification (2)](https://blog.pocp.com/blog/tag/ehr-certification) - [EHR Guides (2)](https://blog.pocp.com/blog/tag/ehr-guides) - [EHRs (2)](https://blog.pocp.com/blog/tag/ehrs) - [Epic (2)](https://blog.pocp.com/blog/tag/epic) - [Formulary and Benefit (2)](https://blog.pocp.com/blog/tag/formulary-and-benefit) - [H.R. 6 (2)](https://blog.pocp.com/blog/tag/h-r-6) - [Market Assessment (2)](https://blog.pocp.com/blog/tag/market-assessment) - [Medical Benefit (2)](https://blog.pocp.com/blog/tag/medical-benefit) - [Medical Pharmacy Benefit Integration (2)](https://blog.pocp.com/blog/tag/medical-pharmacy-benefit-integration) - [Medicare Payment Reform (2)](https://blog.pocp.com/blog/tag/medicare-payment-reform) - [Medication Adherence (2)](https://blog.pocp.com/blog/tag/medication-adherence) - [Member Data (2)](https://blog.pocp.com/blog/tag/member-data) - [NCPDP Telecommunications Standard Version F6 (2)](https://blog.pocp.com/blog/tag/ncpdp-telecommunications-standard-version-f6) - [ONC Physician Burden Reduction (2)](https://blog.pocp.com/blog/tag/onc-physician-burden-reduction) - [Opioid prescribing laws (2)](https://blog.pocp.com/blog/tag/opioid-prescribing-laws) - [PGx (2)](https://blog.pocp.com/blog/tag/pgx) - [Part D (2)](https://blog.pocp.com/blog/tag/part-d) - [Patient Record Sharing (2)](https://blog.pocp.com/blog/tag/patient-record-sharing) - [Pharmaceutical Manufacturers (2)](https://blog.pocp.com/blog/tag/pharmaceutical-manufacturers) - [Policy monitoring (2)](https://blog.pocp.com/blog/tag/policy-monitoring) - [Pre-approval Information Exchange (2)](https://blog.pocp.com/blog/tag/pre-approval-information-exchange) - [Precision Medicine (2)](https://blog.pocp.com/blog/tag/precision-medicine) - [REMS (2)](https://blog.pocp.com/blog/tag/rems) - [Regulatory landscape (2)](https://blog.pocp.com/blog/tag/regulatory-landscape) - [Specialty Pharmacy Automation (2)](https://blog.pocp.com/blog/tag/specialty-pharmacy-automation) - [Specialty ePrescribing (2)](https://blog.pocp.com/blog/tag/specialty-eprescribing) - [Speed to Medication Therapy (2)](https://blog.pocp.com/blog/tag/speed-to-medication-therapy) - [Telehealth (2)](https://blog.pocp.com/blog/tag/telehealth) - [Telemedicine (2)](https://blog.pocp.com/blog/tag/telemedicine) - [care coordination (2)](https://blog.pocp.com/blog/tag/care-coordination) - [compliance (2)](https://blog.pocp.com/blog/tag/compliance) - [ePA (2)](https://blog.pocp.com/blog/tag/epa) - [eRx (2)](https://blog.pocp.com/blog/tag/erx) - [health dashboards (2)](https://blog.pocp.com/blog/tag/health-dashboards) - [medication management (2)](https://blog.pocp.com/blog/tag/medication-management) - [opioid abuse (2)](https://blog.pocp.com/blog/tag/opioid-abuse) - [patient access (2)](https://blog.pocp.com/blog/tag/patient-access) - [pharmacist (2)](https://blog.pocp.com/blog/tag/pharmacist) - [pharmacy business model (2)](https://blog.pocp.com/blog/tag/pharmacy-business-model) - [prior authorizations (2)](https://blog.pocp.com/blog/tag/prior-authorizations) - [wearables (2)](https://blog.pocp.com/blog/tag/wearables) - [ACO (1)](https://blog.pocp.com/blog/tag/aco) - [AI Policy (1)](https://blog.pocp.com/blog/tag/ai-policy) - [Antikickback Statutes Reform (1)](https://blog.pocp.com/blog/tag/antikickback-statutes-reform) - [Biologics and Biosimilars Naming (1)](https://blog.pocp.com/blog/tag/biologics-and-biosimilars-naming) - [Biosimilars (1)](https://blog.pocp.com/blog/tag/biosimilars) - [Business Process (1)](https://blog.pocp.com/blog/tag/business-process) - [CAQH Phase V Operating Rules (1)](https://blog.pocp.com/blog/tag/caqh-phase-v-operating-rules) - [CARIN Alliance (1)](https://blog.pocp.com/blog/tag/carin-alliance) - [CDS Hooks (1)](https://blog.pocp.com/blog/tag/cds-hooks) - [CMS Attachments Rule (1)](https://blog.pocp.com/blog/tag/cms-attachments-rule) - [CMS-0062P (1)](https://blog.pocp.com/blog/tag/cms-0062p) - [CRD (1)](https://blog.pocp.com/blog/tag/crd) - [Canada Biosimilars Naming (1)](https://blog.pocp.com/blog/tag/canada-biosimilars-naming) - [Canadian ePrescribing (1)](https://blog.pocp.com/blog/tag/canadian-eprescribing) - [Chronic Disease (1)](https://blog.pocp.com/blog/tag/chronic-disease) - [Clinical Quality Language (CQL) (1)](https://blog.pocp.com/blog/tag/clinical-quality-language-cql) - [CodeX (1)](https://blog.pocp.com/blog/tag/codex) - [CoverMyMeds (1)](https://blog.pocp.com/blog/tag/covermymeds) - [DSMO (1)](https://blog.pocp.com/blog/tag/dsmo) - [DTR (1)](https://blog.pocp.com/blog/tag/dtr) - [DTx (1)](https://blog.pocp.com/blog/tag/dtx) - [Data Modernization Initiative (1)](https://blog.pocp.com/blog/tag/data-modernization-initiative) - [Data quality (1)](https://blog.pocp.com/blog/tag/data-quality) - [Designated Standards Maintenance Organizations (1)](https://blog.pocp.com/blog/tag/designated-standards-maintenance-organizations) - [Digital Therapeutics Opportunities (1)](https://blog.pocp.com/blog/tag/digital-therapeutics-opportunities) - [Digital Therapeutics Outlook (1)](https://blog.pocp.com/blog/tag/digital-therapeutics-outlook) - [Discover Alliance (1)](https://blog.pocp.com/blog/tag/discover-alliance) - [Drug Launch (1)](https://blog.pocp.com/blog/tag/drug-launch) - [Drug Manufacturers (1)](https://blog.pocp.com/blog/tag/drug-manufacturers) - [Drug PA (1)](https://blog.pocp.com/blog/tag/drug-pa) - [Drug abuse (1)](https://blog.pocp.com/blog/tag/drug-abuse) - [EHR Apps (1)](https://blog.pocp.com/blog/tag/ehr-apps) - [Enforcement (1)](https://blog.pocp.com/blog/tag/enforcement) - [FDA (1)](https://blog.pocp.com/blog/tag/fda) - [FQHC (1)](https://blog.pocp.com/blog/tag/fqhc) - [Federally Qualified Health Centers (1)](https://blog.pocp.com/blog/tag/federally-qualified-health-centers) - [Fee-for-service (1)](https://blog.pocp.com/blog/tag/fee-for-service) - [Gold-carding (1)](https://blog.pocp.com/blog/tag/gold-carding) - [HIN (1)](https://blog.pocp.com/blog/tag/hin) - [HIPAA (1)](https://blog.pocp.com/blog/tag/hipaa) - [HIT Leaders (1)](https://blog.pocp.com/blog/tag/hit-leaders) - [HTI-4 (1)](https://blog.pocp.com/blog/tag/hti-4) - [Health and Human Services (1)](https://blog.pocp.com/blog/tag/health-and-human-services) - [Health data (1)](https://blog.pocp.com/blog/tag/health-data) - [Health system (1)](https://blog.pocp.com/blog/tag/health-system) - [Healthcare artificial intelligence trends (1)](https://blog.pocp.com/blog/tag/healthcare-artificial-intelligence-trends) - [Human Services (1)](https://blog.pocp.com/blog/tag/human-services) - [Hypertension (1)](https://blog.pocp.com/blog/tag/hypertension) - [I-STOP (1)](https://blog.pocp.com/blog/tag/i-stop) - [Insurance (1)](https://blog.pocp.com/blog/tag/insurance) - [Landscape analysis (1)](https://blog.pocp.com/blog/tag/landscape-analysis) - [MACRA (1)](https://blog.pocp.com/blog/tag/macra) - [MIPS (1)](https://blog.pocp.com/blog/tag/mips) - [Market Intelligence (1)](https://blog.pocp.com/blog/tag/market-intelligence) - [Market Research (1)](https://blog.pocp.com/blog/tag/market-research) - [Medication Therapy Management (1)](https://blog.pocp.com/blog/tag/medication-therapy-management) - [Modernizing Part D CMS-4180-P (1)](https://blog.pocp.com/blog/tag/modernizing-part-d-cms-4180-p) - [NCPDP F&B (1)](https://blog.pocp.com/blog/tag/ncpdp-fb) - [NCPDP SCRIPT 2017071 (1)](https://blog.pocp.com/blog/tag/ncpdp-script-2017071) - [NCPDP Workgroups (1)](https://blog.pocp.com/blog/tag/ncpdp-workgroups) - [NCQA (1)](https://blog.pocp.com/blog/tag/ncqa) - [NPI (1)](https://blog.pocp.com/blog/tag/npi) - [Objective Analysis (1)](https://blog.pocp.com/blog/tag/objective-analysis) - [Outcomes (1)](https://blog.pocp.com/blog/tag/outcomes) - [P2 FHIR Taskforce (1)](https://blog.pocp.com/blog/tag/p2-fhir-taskforce) - [PAS (1)](https://blog.pocp.com/blog/tag/pas) - [PBMs (1)](https://blog.pocp.com/blog/tag/pbms) - [PIE (1)](https://blog.pocp.com/blog/tag/pie) - [POCP News (1)](https://blog.pocp.com/blog/tag/pocp-news) - [Pain Management (1)](https://blog.pocp.com/blog/tag/pain-management) - [Pharmacogenomics (1)](https://blog.pocp.com/blog/tag/pharmacogenomics) - [Population Health Management (1)](https://blog.pocp.com/blog/tag/population-health-management) - [Prescribing Authority (1)](https://blog.pocp.com/blog/tag/prescribing-authority) - [Prescribing signatures (1)](https://blog.pocp.com/blog/tag/prescribing-signatures) - [Prescription Price Transparency (1)](https://blog.pocp.com/blog/tag/prescription-price-transparency) - [Prescription affordability (1)](https://blog.pocp.com/blog/tag/prescription-affordability) - [Prescription drug benefit (1)](https://blog.pocp.com/blog/tag/prescription-drug-benefit) - [Prescription pricing (1)](https://blog.pocp.com/blog/tag/prescription-pricing) - [Public Health (1)](https://blog.pocp.com/blog/tag/public-health) - [Quality Measures (1)](https://blog.pocp.com/blog/tag/quality-measures) - [Quality Reporting (1)](https://blog.pocp.com/blog/tag/quality-reporting) - [RTBT (1)](https://blog.pocp.com/blog/tag/rtbt) - [RTPB (1)](https://blog.pocp.com/blog/tag/rtpb) - [Regulatory overhead (1)](https://blog.pocp.com/blog/tag/regulatory-overhead) - [RelayHealth (1)](https://blog.pocp.com/blog/tag/relayhealth) - [Rx renewal (1)](https://blog.pocp.com/blog/tag/rx-renewal) - [RxBC (1)](https://blog.pocp.com/blog/tag/rxbc) - [Sandbox (1)](https://blog.pocp.com/blog/tag/sandbox) - [Social Determinants of Health (1)](https://blog.pocp.com/blog/tag/social-determinants-of-health) - [Specialty Pharmacy Enrollment (1)](https://blog.pocp.com/blog/tag/specialty-pharmacy-enrollment) - [Specialty medication (1)](https://blog.pocp.com/blog/tag/specialty-medication) - [Stark Anti-Kickback Statute (1)](https://blog.pocp.com/blog/tag/stark-anti-kickback-statute) - [Stark Law Reform (1)](https://blog.pocp.com/blog/tag/stark-law-reform) - [State policy (1)](https://blog.pocp.com/blog/tag/state-policy) - [Surescripts (1)](https://blog.pocp.com/blog/tag/surescripts) - [Telecommunications (1)](https://blog.pocp.com/blog/tag/telecommunications) - [Telehealth / Telemedicine (1)](https://blog.pocp.com/blog/tag/telehealth-telemedicine) - [U.S. Senate Special Committee on Aging (1)](https://blog.pocp.com/blog/tag/u-s-senate-special-committee-on-aging) - [Uncategorized (1)](https://blog.pocp.com/blog/tag/uncategorized) - [Virtual Visits (1)](https://blog.pocp.com/blog/tag/virtual-visits) - [Working from home (1)](https://blog.pocp.com/blog/tag/working-from-home) - [X12 (1)](https://blog.pocp.com/blog/tag/x12) - [blockchain (1)](https://blog.pocp.com/blog/tag/blockchain) - [care gaps (1)](https://blog.pocp.com/blog/tag/care-gaps) - [community pharmacy (1)](https://blog.pocp.com/blog/tag/community-pharmacy) - [consumerism (1)](https://blog.pocp.com/blog/tag/consumerism) - [data platforms (1)](https://blog.pocp.com/blog/tag/data-platforms) - [digiceuticals (1)](https://blog.pocp.com/blog/tag/digiceuticals) - [digital health platforms (1)](https://blog.pocp.com/blog/tag/digital-health-platforms) - [eConsent (1)](https://blog.pocp.com/blog/tag/econsent) - [eMedication Management (1)](https://blog.pocp.com/blog/tag/emedication-management) - [healthcare (1)](https://blog.pocp.com/blog/tag/healthcare) - [home health (1)](https://blog.pocp.com/blog/tag/home-health) - [machine learning (1)](https://blog.pocp.com/blog/tag/machine-learning) - [medical deserts (1)](https://blog.pocp.com/blog/tag/medical-deserts) - [patient generated data (1)](https://blog.pocp.com/blog/tag/patient-generated-data) - [payers (1)](https://blog.pocp.com/blog/tag/payers) - [payment model (1)](https://blog.pocp.com/blog/tag/payment-model) - [prescription drug monitoring programs (1)](https://blog.pocp.com/blog/tag/prescription-drug-monitoring-programs) - [rural health (1)](https://blog.pocp.com/blog/tag/rural-health) - [vive (1)](https://blog.pocp.com/blog/tag/vive) See all [![Point-of-Care Partners](https://blog.pocp.com/hubfs/PointOfCarePartners_January2020/images/pocp-web-retina-logo-footer.jpg "Point-of-Care Partners")](https://www.pocp.com) ©2026 Point-of-Care Partners | All Rights Reserved - [![Twitter](https://blog.pocp.com/hubfs/PointOfCarePartners_January2020/images/Twitter-icon.png "Twitter")](https://twitter.com/pocpHIT) - [![LinkedIn](https://blog.pocp.com/hubfs/PointOfCarePartners_January2020/images/linkedin-icon.png "LinkedIn")](http://www.linkedin.com/company/point-of-care-partners) - [![RSS](https://blog.pocp.com/hubfs/PointOfCarePartners_January2020/images/rss-icon.png "RSS")](https://www.pocp.com/pocp-blog/) ```json { "@context" : "https://schema.org", "@type" : "BlogPosting", "author" : { "@type" : "Person", "name" : "Michael Burger", "url" : "https://blog.pocp.com/blog/author/michael-burger" }, "dateModified" : "2020-06-19T18:42:40.974Z", "datePublished" : "2016-03-29T15:50:21.000Z", "headline" : "Extraneous ePrescription Notes: Best Addressed by the Sender", "mainEntityOfPage" : { "@id" : "https://blog.pocp.com/blog/extraneous-eprescription-notes-best-addressed-by-the-sender", "@type" : "WebPage" }, "publisher" : { "@type" : "Organization", "logo" : { "@type" : "ImageObject", "url" : "https://blog.pocp.com/hubfs/pocp-logo-2016.jpg" }, "name" : "Point-of-Care Partners" } } ```